Getachew, Robel <br/><br/>
PDGF beta-receptor kinase activity and ERK1/2 mediate glycosaminoglycan elongation on biglycan and increases binding to LDL.  [electronic resource] 

 -  Endocrinology  Sep 2010 
 - 4356-67 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1945-7170 
<br/><br/><label>Standard No.: </label>10.1210/en.2010-0027  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Aorta--drug effects<br/>Apolipoproteins E--genetics<br/>Benzamides<br/>Biglycan<br/>Cells, Cultured<br/>Dietary Fats--administration & dosage<br/>Extracellular Matrix Proteins--metabolism<br/>Extracellular Signal-Regulated MAP Kinases--metabolism<br/>Glycosaminoglycans--metabolism<br/>Humans<br/>Imatinib Mesylate<br/>Lipids--analysis<br/>Lipoproteins, LDL--metabolism<br/>Male<br/>Mice<br/>Mice, Knockout<br/>Mitogen-Activated Protein Kinase 1--metabolism<br/>Mitogen-Activated Protein Kinase 3--metabolism<br/>Muscle, Smooth, Vascular--cytology<br/>Phosphorylation--drug effects<br/>Piperazines--pharmacology<br/>Platelet-Derived Growth Factor--pharmacology<br/>Protein Binding--drug effects<br/>Protein Kinase Inhibitors--pharmacology<br/>Protein-Tyrosine Kinases--antagonists & inhibitors<br/>Proteoglycans--metabolism<br/>Pyrimidines--pharmacology<br/>RNA Interference<br/>Receptor, Platelet-Derived Growth Factor beta--genetics